Victor Cervera
Company: TILT Biotherapeutics Ltd.
Job title: Vice President - Business Development
Seminars:
TNF Alpha & IL-2 Expressing Oncolytic Adenovirus to Enable T-cell Therapies 2:10 pm
• How using an oncolytic virus can overcome some of the limitations of T-cell therapy • How the treatments induce immune changes in tumor and blood of patients • How the approach results in immunotherapy naïve patients vs those that progressed upon immunotherapyRead more
day: Day One
Chair’s Opening Remarks 8:50 am
day: Day Two